159 related articles for article (PubMed ID: 12429974)
21. Selective protection of mitogenically stimulated human lymphocytes but not leukemic cells from cytosine arabinoside-induced apoptosis by LY294002, a phosphoinositol-3 kinase inhibitor.
Du L; Smolewski P; Bedner E; Traganos F; Darzynkiewicz Z
Int J Oncol; 2001 Oct; 19(4):811-9. PubMed ID: 11562760
[TBL] [Abstract][Full Text] [Related]
22. Role of the N terminus in RNase A homologues: differences in catalytic activity, ribonuclease inhibitor interaction and cytotoxicity.
Boix E; Wu Y; Vasandani VM; Saxena SK; Ardelt W; Ladner J; Youle RJ
J Mol Biol; 1996 Apr; 257(5):992-1007. PubMed ID: 8632481
[TBL] [Abstract][Full Text] [Related]
23. Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.
Lee I; Kalota A; Gewirtz AM; Shogen K
Anticancer Res; 2007; 27(1A):299-307. PubMed ID: 17352247
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive comparison of the cytotoxic activities of onconase and bovine seminal ribonuclease.
Matousek J; Soucek J; Slavík T; Tománek M; Lee JE; Raines RT
Comp Biochem Physiol C Toxicol Pharmacol; 2003 Dec; 136(4):343-56. PubMed ID: 15012906
[TBL] [Abstract][Full Text] [Related]
25. Tumoricidal effects of onconase on various tumors.
Lee I; Lee YH; Mikulski SM; Lee J; Covone K; Shogen K
J Surg Oncol; 2000 Mar; 73(3):164-71. PubMed ID: 10738271
[TBL] [Abstract][Full Text] [Related]
26. Multiparameter analysis of progeny of individual cells by laser scanning cytometry.
Bedner E; Ruan Q; Chen S; Kamentsky LA; Darzynkiewicz Z
Cytometry; 2000 Aug; 40(4):271-9. PubMed ID: 10918278
[TBL] [Abstract][Full Text] [Related]
27. Possible mechanisms of improved radiation response by cytotoxic RNase, Onconase, on A549 human lung cancer xenografts of nude mice.
Kim DH; Kim EJ; Kalota A; Gewirtz AM; Glickson J; Shogen K; Lee I
Adv Exp Med Biol; 2007; 599():53-9. PubMed ID: 17727247
[TBL] [Abstract][Full Text] [Related]
28. Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.
Ita M; Halicka HD; Tanaka T; Kurose A; Ardelt B; Shogen K; Darzynkiewicz Z
Cancer Biol Ther; 2008 Jul; 7(7):1104-8. PubMed ID: 18443430
[TBL] [Abstract][Full Text] [Related]
29. Contribution of active-site residues to the function of onconase, a ribonuclease with antitumoral activity.
Lee JE; Raines RT
Biochemistry; 2003 Oct; 42(39):11443-50. PubMed ID: 14516195
[TBL] [Abstract][Full Text] [Related]
30. Onconase, an anti-tumor ribonuclease suppresses intracellular oxidative stress.
Ardelt B; Juan G; Burfeind P; Salomon T; Wu JM; Hsieh TC; Li X; Sperry R; Pozarowski P; Shogen K; Ardelt W; Darzynkiewicz Z
Int J Oncol; 2007 Sep; 31(3):663-9. PubMed ID: 17671695
[TBL] [Abstract][Full Text] [Related]
31. Mild hyperthermia predisposes tumor cells to undergo apoptosis upon treatment with onconase.
Halicka HD; Ardelt B; Shogen K; Darzynkiewicz Z
Int J Oncol; 2007 Apr; 30(4):841-7. PubMed ID: 17332922
[TBL] [Abstract][Full Text] [Related]
32. Ribonucleases as novel chemotherapeutics : the ranpirnase example.
Lee JE; Raines RT
BioDrugs; 2008; 22(1):53-8. PubMed ID: 18215091
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclins A, D2 and D3 in individual normal mitogen stimulated lymphocytes and in MOLT-4 leukemic cells analyzed by multiparameter flow cytometry.
Gong J; Bhatia U; Traganos F; Darzynkiewicz Z
Leukemia; 1995 May; 9(5):893-9. PubMed ID: 7769853
[TBL] [Abstract][Full Text] [Related]
34. Ranpirnase (Onconase), a cytotoxic amphibian ribonuclease, manipulates tumour physiological parameters as a selective killer and a potential enhancer for chemotherapy and radiation in cancer therapy.
Lee I
Expert Opin Biol Ther; 2008 Jun; 8(6):813-27. PubMed ID: 18476793
[TBL] [Abstract][Full Text] [Related]
35. The therapeutic mechanisms of ranpirnase-induced enhancement of radiation response on A549 human lung cancer.
Lee I; Kim DH; Sunar U; Magnitsky S; Shogen K
In Vivo; 2007; 21(5):721-8. PubMed ID: 18019404
[TBL] [Abstract][Full Text] [Related]
36. Interferon enhances the activity of the anticancer ribonuclease, onconase.
Vasandani VM; Castelli JC; Hott JS; Saxena S; Mikulski SM; Youle RJ
J Interferon Cytokine Res; 1999 May; 19(5):447-54. PubMed ID: 10386856
[TBL] [Abstract][Full Text] [Related]
37. The crystal structure of the domain-swapped dimer of onconase highlights some catalytic and antitumor activity features of the enzyme.
Gotte G; Campagnari R; Loreto D; Bettin I; Calzetti F; Menegazzi M; Merlino A
Int J Biol Macromol; 2021 Nov; 191():560-571. PubMed ID: 34563576
[TBL] [Abstract][Full Text] [Related]
38. Single amino acid substitutions at the N-terminus of a recombinant cytotoxic ribonuclease markedly influence biochemical and biological properties.
Newton DL; Boque L; Wlodawer A; Huang CY; Rybak SM
Biochemistry; 1998 Apr; 37(15):5173-83. PubMed ID: 9548748
[TBL] [Abstract][Full Text] [Related]
39. Caspase activation in response to cytotoxic Rana catesbeiana ribonuclease in MCF-7 cells.
Hu CC; Tang CH; Wang JJ
FEBS Lett; 2001 Aug; 503(1):65-8. PubMed ID: 11513856
[TBL] [Abstract][Full Text] [Related]
40. The cytotoxic ribonuclease onconase targets RNA interference (siRNA).
Zhao H; Ardelt B; Ardelt W; Shogen K; Darzynkiewicz Z
Cell Cycle; 2008 Oct; 7(20):3258-61. PubMed ID: 18927512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
